Vincenzo Cardinale Selected Research

Vincenzo Cardinale Research Topics

Disease

16	Neoplasms (Cancer) 02/2024 - 07/2013
14	Cholangiocarcinoma 06/2024 - 06/2012
13	Liver Diseases (Liver Disease) 01/2023 - 07/2013
6	Fibrosis (Cirrhosis) 04/2024 - 12/2014
5	Inflammation (Inflammations) 12/2023 - 01/2020
5	Obesity 01/2023 - 01/2022
3	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022 - 12/2014
2	Portal Hypertension 04/2024 - 12/2023
2	Thrombosis (Thrombus) 04/2024 - 01/2022
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023 - 01/2020
2	Non-alcoholic Fatty Liver Disease 09/2022 - 01/2020
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 01/2018
2	Sclerosing Cholangitis 01/2022 - 01/2020
2	Diabetes Mellitus 01/2018 - 07/2013
2	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2010 - 02/2008
1	Ascites 04/2024
1	Hepatic Encephalopathy 04/2024
1	Hemorrhage 04/2024
1	Bacterial Infections (Bacterial Infection) 12/2023
1	Thrombophilia 12/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2023
1	End Stage Liver Disease 01/2023
1	Dysbiosis 08/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 08/2022
1	Insulin Resistance 08/2022
1	COVID-19 06/2022
1	Overweight 01/2022
1	Hepatitis 01/2022
1	Disease Progression 01/2022
1	Tyrosinemias (Tyrosinemia) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Choledocholithiasis 01/2022
1	Cholestasis 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Adenocarcinoma 01/2021
1	Ischemia 01/2020
1	Carcinoma in Situ 08/2019

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
3	LipopolysaccharidesIBA 12/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2017
3	MucinsIBA 01/2019 - 06/2012
2	Alkaline PhosphataseIBA 11/2022 - 01/2018
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022 - 01/2018
2	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2022 - 01/2021
2	Insulin (Novolin)FDA Link 01/2021 - 01/2015
1	Keratin-7 (Cytokeratin 7)IBA 02/2024
1	von Willebrand FactorIBA 12/2023
1	Factor VIII (Coagulation Factor VIII)IBA 12/2023
1	EndotoxinsIBA 12/2023
1	zonulinIBA 12/2023
1	Glycoproteins (Glycoprotein)IBA 12/2023
1	SelectinsIBA 12/2023
1	LipidsIBA 12/2022
1	Choline (Choline Chloride)IBA 09/2022
1	Methionine (L-Methionine)FDA Link 09/2022
1	Mineral WatersIBA 09/2022
1	Bicarbonates (Hydrogen Carbonate)IBA 09/2022
1	Calcium Sulfate (Alabaster)IBA 09/2022
1	Inositol (Myoinositol)IBA 08/2022
1	Lactalbumin (alpha-Lactalbumin)IBA 08/2022
1	PrebioticsIBA 08/2022
1	VaccinesIBA 06/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	secretin receptorIBA 01/2022
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	HydrolasesIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	NanogelsIBA 01/2022
1	acetoacetic acid (acetoacetate)IBA 01/2022
1	nasIBA 01/2022
1	Thrombospondin 1IBA 12/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	RetinoidsIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	locked nucleic acidIBA 01/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Bile Pigments (Bilin)IBA 08/2019
1	Collagen Type III (Type III Collagen)IBA 01/2019
1	CollagenIBA 01/2019
1	MesothelinIBA 05/2018

Therapy/Procedure

17	Therapeutics 06/2024 - 12/2011
7	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 07/2013
3	Bariatric Surgery 01/2023 - 01/2022
3	Liver Transplantation 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 09/2023 - 01/2020
2	Immunotherapy 01/2023 - 10/2021
2	Precision Medicine 10/2021 - 05/2021
2	Transplantation 01/2018 - 12/2014
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 04/2024
1	Critical Care (Surgical Intensive Care) 04/2024
1	Transjugular Intrahepatic Portasystemic Shunt 04/2024
1	Cell Transplantation 01/2023
1	Obesity Management 01/2023